US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 7.460
  • +0.060+0.81%
Trading May 15 13:26 ET
173.81MMarket Cap-1865P/E (TTM)

Outlook Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: May 15, 2024

Based on 4 analysts giving stock ratings to Outlook Therapeutics in the past 3 months

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: May 15, 2024

The average Outlook Therapeutics stock price target is 37.50 with a max estimate of 50.00 and a min estimate of 25.00

Review Outlook Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: May 15, 2024

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: May 15, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg